Figure 1S from Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma

openalex(2023)

引用 0|浏览0
暂无评分
摘要
Consort diagram
更多
查看译文
关键词
renal cell carcinoma,sunitinib,first-line
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要